5% TB patients in UP elude detection: Data

  • | Monday | 4th December, 2023

Lucknow: Despite concerted efforts, about 5% of estimated TB patients in Uttar Pradesh are still not detected, suggests data from National TB Division of the Union ministry of health and family welfare.The TB notification target for UP is 5,50,000, which includes a goal of 3,64,000 for the government sector and the remaining 1,86,000 for the private sector. Against the target, public sector hospitals recorded an achievement of 102.5% but the private sector was able to achieve 80.4% of the expected target. Cumulatively, 95% target was realized which speaks for a gap of about 5%. Data also indicated that one in five TB patients being diagnosed in the private sector are missed from the loop of treatment. Experts revealed that while on one hand, the missed cases impede states performance vis-à-vis Stop TB goals, they add to the risk of latent TB in which the symptoms are not dominant and visible. Global health agencies have noted that TB is the second leading infectious killer after Covid-19 and HIV. Approximately 33% of the worlds population has latent tuberculosis infection which makes screening for mycobacterium tuberculosis infection essential for public health. Experts said over the past five years, technology has helped India bring down TB prevalence significantly. Earlier, the focus was largely identifying ailing persons and putting them on treatment but now the focus includes screening of TB at the level of infection and eliminating it, said Dr Rajendra Prasad, vice chairman, National Task Force, TB Elimination Programme (for medical college involvement). Citing an example, he said, A new test is now available in the private sector which can help diagnosis of TB infection even in challenging patients like the immune-suppressed or the BCG vaccinated. Besides, it can give reliable outcomes in one go against the available variant of TB skin test (Mantoux) which requires a patient to give sample one day and then come again for a second visit 72 hours later. Many people do not return for the follow up reading. The test called Interferon Gamma Release Assay or IGRA (commercially known as Revvitys T-SPOT) was launched at a medical conference at KGMU Lucknow last week. Speaking to TOI, president India and South Asia for the manufacturer company, Shripad Joshi said: Estimates show that approximately 40% Indians carry latent TB and its detection before it progresses to active disease is paramount. This advanced screening tool can help in aiding Indias Stop TB campaign.

If You Like This Story, Support NYOOOZ



Your support to NYOOOZ will help us to continue create and publish news for and from smaller cities, which also need equal voice as much as citizens living in bigger cities have through mainstream media organizations.

Stay updated with all the Lucknow Latest News headlines here. For more exclusive & live news updates from all around India, stay connected with NYOOOZ.

Related Articles

Guidelines for voters
  • Tuesday | 27th February, 2024
Raja Bhaiya’s party to support BJP
  • Tuesday | 27th February, 2024